𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin

✍ Scribed by Yutaka Ueda; Takahito Miyake; Tomomi Egawa-Takata; Takashi Miyatake; Shinya Matsuzaki; Takuhei Yokoyama; Kiyoshi Yoshino; Masami Fujita; Takayuki Enomoto; Tadashi Kimura

Publisher
Springer
Year
2010
Tongue
English
Weight
199 KB
Volume
67
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Second-line treatment with carboplatin f
Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy : A Phase II study
✍ Riccardo Soffietti; Mauro Nobile; Roberta RudΓ ; Marzia Borgognone; Alessandra Co πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND The efficacy of second‐line chemotherapy for patients with recurrent or progressive oligodendroglial tumors is limited. In the current study, the authors investigated the use of carboplatin as a second‐line chemotherapeutic agent against these types of tumors. ## METHODS

Phase II trial of chemotherapy with 5-fl
Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type
✍ Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or